<DOC>
	<DOCNO>NCT01479439</DOCNO>
	<brief_summary>Sickle cell disease cause kidney damage increase age , lead chronic kidney disease renal failure nearly one third patient sickle cell disease . Currently , treatment sickle cell relate kidney disease .</brief_summary>
	<brief_title>Losartan Reverse Sickle Nephropathy</brief_title>
	<detailed_description>The purpose research study see losartan help reduce reverse damage do kidney child adult Sickle Cell Anemia ( SCA ) Sickle Beta-zero ( HbSβ0 ) Thalassemia .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>1 . Age ≥6 year age ; albuminuria ( NoA ) group age ≥ 6 year &lt; 21 year age 2 . Diagnosis hemoglobin SS disease Sβ0 thalassemia hemoglobin electrophoresis and/or βglobin gene mapping . 3 . Urine osmolality &lt; 700 mOsm first morning urine 4 . Written informed consent ( assent , applicable ) 5 . Documented urine albumin level show either NoA : ,.UAlb &lt; 30mg/g creatinine first morning urine MiA : UAlb 30300 mg/g creatinine first morning urine MaA : UAlb &gt; 300 mg/g creatinine first morning urine sample 6 . A documented negative serum pregnancy test females child bear potential great 10 year age within ( prior ) 7 day start study medication . 7 . Subjects childbearing potential must willing use medically accept form contraception throughout study . 8 . Patients hydroxyurea stable ( change ) dose HU three month prior study entry . 1 . Patients Hb SC , SD , Sβ+thal , SE sickle hemoglobinopathy , sickle trait ( AS ) . 2 . Pregnant lactating female , female childbearing potential unable use medically accept form contraception throughout study . 3 . Urine creatinine clearance ( Clcr ) &lt; 60 mL/minute/1.73 m2 4 . Gross ( microscopic ) hematuria . If hematuria resolve 2 week , patient eligible . 5 . Hyperkalemia ( K≥5.5 ) baseline despite low potassium diet 6 . Concurrent condition predisposes nephropathy , lupus , diabetes , hypertension , control medications.. 7 . On reninangiotensin pathway inhibitor ( e.g. , captopril , lisinopril , Losartan , valsartan , etc ) last two week prior enrollment . 8 . Hypersensitivity Angiotensin II receptor blocker losartan , valsartan , telmisartan . 9 . Patients red cell apheresis ongoing aggressive chronic transfusion ( one month goal HbS &lt; 30 % ) . Patients receive simple transfusion symptom acute event eligible , receive partial full exchange transfusion acute event , eligible 90 day . 10 . Hepatic dysfunction define ALT direct bilirubin &gt; 3X upper limit normal ( ULN ) . 11 . Chronic therapy NSAIDS Cox2 inhibitor 12 . On another interventional trial . May eligible two week completion another interventional study . 13 . Any condition interfere ability patient understand comply treatment plan follow . 14 . A serious mental physical illness major disease ( cardiac , renal , hepatic , neurological , endocrine , metabolic , pulmonary function psychiatric ) , opinion investigator would compromise participation study . 15 . Unable take oral medication . 16 . HIV confirm positive . 17 . Chronic therapy steroid . May eligible three week complete steroid therapy . 18 . Patients lithium exclude</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>